Abstract
The corresponding author recently notified the JCI that the patient data presented in Figure 1B were not correct. Analysis of the correct patient data set does not show a significant difference in CERS6expression in human lung adenocarcinomas with positive invasive growth (definite) compared with those with negligible invasive growth or without invasive growth (focal/none). The Editors have requested an institutional investigation into this matter, and we will inform our readers of the outcome when the investigation is complete.
| Original language | English |
|---|---|
| Pages (from-to) | 3464 |
| Number of pages | 1 |
| Journal | Journal of Clinical Investigation |
| Volume | 129 |
| Issue number | 8 |
| DOIs |
|
| Publication status | Published - 01-08-2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- General Medicine
Fingerprint
Dive into the research topics of 'Erratum: Targeting ceramide synthase 6–dependent metastasis-prone phenotype in lung cancer cells Citation for this expression of concern (Journal of Clinical Investigation (2019) 129:8 (3464) Doi:10.1172/JCI131245)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver